Invention Grant
US08481597B2 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia 有权
( - )(3-三卤代甲基苯氧基)(4-卤代苯基)乙酸衍生物用于治疗胰岛素抵抗,2型糖尿病,高脂血症和高尿酸血症

  • Patent Title: Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
  • Patent Title (中): ( - )(3-三卤代甲基苯氧基)(4-卤代苯基)乙酸衍生物用于治疗胰岛素抵抗,2型糖尿病,高脂血症和高尿酸血症
  • Application No.: US13432905
    Application Date: 2012-03-28
  • Publication No.: US08481597B2
    Publication Date: 2013-07-09
  • Inventor: Kenneth LuskeyJian Luo
  • Applicant: Kenneth LuskeyJian Luo
  • Applicant Address: US CA Hayward
  • Assignee: Metabolex, Inc.
  • Current Assignee: Metabolex, Inc.
  • Current Assignee Address: US CA Hayward
  • Agency: Hamilton DeSanctis & Cha, LLP
  • Agent Sam L. Nguyen
  • Main IPC: A61K31/20
  • IPC: A61K31/20
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
Abstract:
The present invention provides the use of (−) (3-trihalomethylphenoxy) (4-halophenyl)acetic acid derivatives and compositions in the treatment of insulin resistance, Type 2 diabetes, hyperlipidemia and hyperuricemia.
Information query
Patent Agency Ranking
0/0